Acronym meanings of ARIAD. Acronym & meanings of ARIAD

Wiki AI search on online names & meanings containing ARIAD

ARIAD

ARIAD Pharmaceuticals

ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered

Harvey Berger

executive. He was the founder and chairman and chief executive officer of ARIAD Pharmaceuticals, Inc. for 25 years, starting in 1991 and became advisor

Brigatinib

others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Brigatinib acts as an inhibitor of the receptor tyrosine

Ponatinib

chromosome–positive (Ph+) acute lymphoblastic leukemia. It was developed by Ariad Pharmaceuticals. It is a multi-targeted tyrosine-kinase inhibitor. Some

Takeda Pharmaceutical Company

venture along with Lightstone Ventures. In February 2017, Takeda acquired Ariad Pharmaceuticals for $5.2 billion, expanding the company's oncology and hematology

Perry J. Kaufman

moneymentor.com From ET Business College Ariad GmbH website Aquantum Group website Website of Aquantum Group Website of Ariad GmbH Official website Official KaufmanSignals

Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.

Ariad Pharmaceuticals et al. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010) (en banc), is a United States court case regarding accusations of

List of pharmaceutical companies

Laboratories) Arab Pharmaceutical Manufacturing (1962–2007; acquired by Hikma) ARIAD (1991–2017; merged into Takeda) Astra (1913–1999) Aurora (1995–2001; acquired

Ridaforolimus

sarcoma. Ridaforolimus is being co-developed by Merck and ARIAD Pharmaceuticals. On May 5, 2010, Ariad Pharmaceuticals and Merck & Company announced a clinical

Joan Brugge

general public. In 1992, Brugge joined ARIAD Pharmaceuticals in Cambridge, Massachusetts as its Scientific Director. ARIAD primarily focuses on making drugs